Working… Menu

Study to Evaluate Safety, Tolerability and Pharmacokinetics of ASC42 in Chinese Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04965337
Recruitment Status : Active, not recruiting
First Posted : July 16, 2021
Last Update Posted : October 19, 2021
Information provided by (Responsible Party):
Ascletis Pharmaceuticals Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : August 1, 2021
Estimated Study Completion Date : February 20, 2022